The National Aerospace Laboratories (NAL), based in Bangalore, has been recently in news for its new invention. The organization has developed a non-invasive breathing support device named SwasthVayu. This BiPAP ventilator was designed particularly for usage in non-critical non-ICU cases of Covid-19.
Understanding SwasthVayu – The BiPAP Ventilator
BiPAP stands for Bilevel Positive Airway Pressure, a type of positive pressure ventilator. The functioning of the BiPAP ventilator is distinct as it provides positive air pressure during both inhaling and exhaling processes. However, during inhalation, the air pressure supplied is comparatively higher.
SwasthVayu, the brainchild of NAL, is a BiPAP ventilator that works in conjunction with an oxygen concentrator. It has been recommended for treating moderate to mid-stage severe Covid-19 patients who do not require intubation and invasive ventilation.
Benefits of SwasthVayu
The design of SwasthVayu positions it as an ideal ventilator for several scenarios in the current Indian Covid-19 landscape, such as wards, makeshift hospitals, dispensaries, and home care. One of its most significant advantages is its user-friendly nature. This machine does not require specialized nursing to operate, making it accessible to more widespread use.
In addition to its simplicity, SwasthVayu is also economically efficient and compact. It is composed primarily of indigenous components, further contributing to its cost-effectiveness. Besides, the National Accreditation Board for Testing and Calibration Laboratories (NABL) has certified the system for its safety and performance.
About National Aerospace Laboratories (NAL)
Established in 1959, the National Aerospace Laboratories (NAL) operate under the Council of Scientific and Industrial Research (CSIR), India. It holds the distinction of being the only government aerospace Research & Development laboratory in India’s civilian sector. The creation of SwasthVayu is one of their latest contributions towards combating the Covid-19 situation.
Throughout its journey, NAL has been pivotal in contributing to scientific research and industrial development. The organization’s breakthrough invention, the BiPAP ventilator, further exemplifies NAL’s commitment to community welfare, especially during challenging times like the current health crisis. The introduction of SwasthVayu could revolutionize the way Covid-19 patients are treated, not just in critical care but also for moderate to severe cases outside ICU settings.
